Dynamic Oxidative Stress and DNA Damage Induced by Oestrogen Deficiency and Protective Effects of Puerarin and 17β-Oestradiol in Ovariectomized Rats

Basic and Clinical Pharmacology and Toxicology

Volumn 111, Issue 2, 2012, Pages 87-91

  Tang, Xu Lei ^a   Liu, Xiao Ju ^a   Tian, Quan ^a   Zhang, Wei ^a  

^a LANZHOU UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; MALONALDEHYDE; PUERARIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BLOOD LEVEL; COMET ASSAY; CONTROLLED STUDY; DNA DAMAGE; DRUG EFFECT; DRUG MEGADOSE; ESTROGEN DEFICIENCY; FEMALE; LIPID PEROXIDATION; LOW DRUG DOSE; LYMPHOCYTE; NONHUMAN; OVARIECTOMY; OXIDATIVE STRESS; POSTMENOPAUSE; PRIORITY JOURNAL; PROTECTION; RAT; TOTAL ANTIOXIDANT CAPACITY;

ANIMALS; ANTIOXIDANTS; COMET ASSAY; DNA DAMAGE; ESTRADIOL; ESTROGENS; FEMALE; ISOFLAVONES; LYMPHOCYTES; MALONDIALDEHYDE; OVARIECTOMY; OXIDATIVE STRESS; PHYTOESTROGENS; RATS; RATS, SPRAGUE-DAWLEY;

RATTUS;

EID: 84864009043     PISSN: 17427835     EISSN: 17427843     Source Type: Journal    
DOI: 10.1111/j.1742-7843.2012.00864.x     Document Type: Article

References (38)

1. Seals DR, Jablonski KL, Donato AJ. Aging and vascular endothelial function in humans. Clin Sci (Lond) 2011;120:357-75.
2. Riggs BL, Khosla S, Melton LJ III. Sex steroids and the construction and conservation of the adult skeleton. Endocr Rev 2002;23:279-302.
3. Finkel T, Holbrook NJ. Oxidants, oxidative stress and biology of aging. Nature 2000;408:239-47.
4. Darabi M, Ani M, Movahedian A, Zarean E, Panjehpour M, Rabbani M. Effect of hormone replacement therapy on total serum anti-oxidant potential and oxidized LDL/β2-glycoprotein I complexes in postmenopausal women. Endocr J 2010;57:1029-34.
5. Gaspard U. Hyperinsulinaemia, a key factor of the metabolic syndrome in postmenopausal women. Maturitas 2009;62:362-5.
6. Gokkusu C, Tata G, Ademoǧlu E, Tamer S. The benefits of hormone replacement therapy on plasma and platelet antioxidant status and fatty acid composition in healthy postmenopausal women. Platelets 2010;21:439-44.
7. Yilmaz N, Eren E. Homocysteine oxidative stress and relation to bone mineral density in post-menopausal osteoporosis. Aging Clin Exp Res 2009;21:353-7.
8. Zucchetto A, Serraino D, Polesel J, Negri E, De Paoli A, Dal Maso L et al. Hormone-related factors and gynecological conditions in relation to endometrial cancer risk. Eur J Cancer Prev 2009;18:316-21.
9. Guo XG, Chen JZ, Zhang X, Xia Q. Effect of puerarin on L-type calcium channel in isolated rat ventricular myocytes. Zhongguo Zhong Yao Za Zhi 2004;29:248-51.
10. Zhang H, Ma LX, Yang XC, Zhang L, Duan JY, Yuan PL. Puerarin inhibits ionic channel current IkI in rat cardiac myocytes. J Fourth Mil Med Univ 2006;27:249-51.
11. Xiong FL, Sun XH, Gan L, Yang XL, Xu HB. Puerarin protects rat pancreatic islets from damage by hydrogen peroxide. Eur J Pharmacol 2006;529:1-7.
12. Zhang HY, Liu YH, Wang HQ, Xu JH, Hu HT. Puerarin protects PC12 cells against beta-amyloid-induced cell injury. Cell Biol Int 2008;32:1230-7.
13. Zheng G, Zhang X, Zheng J, Meng Q, Zheng D. Estrogen-like effects of puerarin and total isoflavones from Pueraria lobata. Zhong Yao Cai 2002;25:566-8.
14. Malaivijitnond S, Tungmunnithum D, Gittarasanee S, Kawin K, Limjunyawong N. Puerarin exhibits weak estrogenic activity in female rats. Fitoterapia 2010;81:569-76.
15. Lam KK, Lee YM, Hsiao G, Chen SY, Yen MH. Estrogen therapy replenishes vascular tetrahydrobiopterin and reduces oxidative stress in ovariectomized rats. Menopause 2006;13:294-302.
16. Crema LM, Diehl LA, Aguiar AP, Almeida L, Fontella FU, Pettenuzzo L et al. Effects of chronic restraint stress and 17-β-estradiol replacement on oxidative stress in the spinal cord of ovariectomized female rats. Neurochem Res 2010;35:1700-7.
17. Singh NP, McCoy MT, Tice RR, Schneider EL. A simple technique for quantitation of low levels of DNA damage in individual cells. Exp Cell Res 1988;175:184-91.
18. Liu X, Zhao J, Zheng R. DNA damage of tumor associated lymphocytes and total antioxidant capacity in cancerous patients. Mutat Res 2003;539:1-8.
19. Tang XL, Liu XJ, Sun WM, Zhao J, Zheng RL. Oxidative stress in Graves' disease patients and antioxidants protected against lymphocytes DNA damage in vitro. Pharmazie 2005;60:696-700.
20. Everett SM, White KLM, Schorah CJ, Calvert RJ, Skinner C, Miller D et al. In vivo DNA damage in gastric epithelial cells. Mutat Res 2000;468:73-85.
21. Benzie IF, Strain JJ. The ferric reducing ability of plasma (FRAP) as a measure of "antioxidant power": the FRAP assay. Anal Biochem 1996;239:70-6.
22. Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979;95:351-8.
23. Zheng RL, Slater TF. Kinetics of lipid peroxidation in rat liver microsomes. Chin Sci Bull 1992;37:325-8.
24. Zhao J, Liu XJ, Ma JW, Zheng RL. DNA damage in healthy term neonate. Early Hum Dev 2004;77:89-98.
25. Schwertz DW, Penckofer S. Sex differences and the effects of sex hormones on hemostasis and vascular reactivity. Heart Lung 2001;30:427-8.
26. Baeza I, Fdez-Tresguerres J, Ariznavarreta C, De la Fuente M. Effects of growth hormone, melatonin, oestrogens and phytoestrogens on the oxidized glutathione (GSSG)/reduced glutathione (GSH) ratio and lipid peroxidation in aged ovariectomized rats. Biogerontology 2010;11:687-701.
27. Behr GA, Schnorr CE, Moreira JC. Increased blood oxidative stress in experimental menopause rat model: the effects of vitamin A low-dose supplementation upon antioxidant status in bilateral ovariectomized rats. Fundam Clin Pharmacol 2011. doi: 10.1111/j.1472-8206.2010.00923.x [Epub ahead of print].
28. Leinonen JS, Ahonen JP, Lönnrot K, Jehkonen M, Dastidar P, Molnár G et al. Low plasma antioxidant activity is associated with high lesion volume and neurological impairment in stroke. Stroke 2000;31:33-9.
29. Pouget JP, Douki T, Richard MJ, Cadet J. DNA damage induced in cells by gamma and UVA radiation as measured by HPLC/GC-MS and HPLC-EC and Comet assay. Chem Res Toxicol 2000;13:541-9.
30. Burner SD, Norman DP, Verdine GL. Structure basis for recognition and repair of the endogenous 8-oxoguanine in DNA. Nature 2000;403:859-66.
31. Gedik CM, Wood SG, Collins AR. Measuring oxidative damage to DNA; HPLC and the comet assay compared. Free Radic Res 1998;29:609-15.
32. Walker SE, AdamsMR, Franke AA, Register TC. Effects of dietary soy protein on iliac and carotid artery atherosclerosis and gene expression in male monkeys. Atherosclerosis 2008;196:106-13.
33. Dijsselbloem N, Vanden Berghe W, De Naeyer A, Haegeman G. Soy isoflavone phyto-pharmaceuticals in interleukin-6 affections. Multi-purpose nutraceuticals at the crossroad of hormone replacement, anti-cancer and anti-inflammatory therapy. Biochem Pharmacol 2004;68:1171-85.
34. Oseni T, Patel R, Pyle J, Jordan VC. Selective estrogen receptor modulators and phytoestrogens. Planta Med 2008;74:1656-65.
35. Lee YJ, Chung HY, Kwak HK, Yoon S. The effects of A. senticosus supplementation on serum lipid profiles, biomarkers of oxidative stress, and lymphocyte DNA damage in postmenopausal women. Biochem Biophys Res Commun 2008;375:44-8.
36. Prasain JK, Jones K, Brissie N, Moore R, Wyss JM, Barnes S. Identification of puerarin and its metabolites in rats by liquid chromatography-tandem mass spectrometry. J Agric Food Chem 2004;52:3708-12.
37. Hwang YP, Jeong HG. Mechanism of phytoestrogen puerarin-mediated cytoprotection following oxidative injury: estrogen receptor-dependent up-regulation of PI3K/Akt and HO-1. Toxicol Appl Pharmacol 2008;233:371-81.
38. Kim SJ, Kwon do Y, Kim YS, Kim YC. Peroxyl radical scavenging capacity of extracts and isolated components from selected medicinal plants. Arch Pharm Res 2010;33:867-73.